NHIF > Benchmarking > 30-Day Hospital Readmission (HRA)

30-day Re-Hospitalization

Enrollment is Open for the 30-Day Hospital Readmission (HRA) Program

The 30-Day Hospital Readmission (HRA) benchmark will help providers to better understand the frequency and reason for re-hospitalization within the first 30 days of home infusion therapy for patients with congestive heart failure (CHF) receiving milrinone or dobutamine; and in parenteral nutrition patients referred for home therapy. These populations were selected for the higher level of complexity associated with the transition of care from hospital to home, and high acuity. This metric is voluntary, meaning if you participate in Patient Satisfaction and Status at Discharge, you do not need to report.